Ying-Hsia Chu, MD

Dr. Chu is a board-certified molecular pathologist with an academic interest in head and neck oncogenesis. Her clinical and scholarly contributions have been recognized with the prestigious Dr. L. Clarke, Jr. and Elaine F. Stout Award from the United States and Canadian Academy of Pathology (USCAP) in 2021 and a Clinical Excellence Honoree distinction from University of Minnesota Physicians in 2026. Beyond her clinical and research roles, Dr. Chu serves on the Editorial Board of Head and Neck Pathology and as a Section Editor for the American Society for Clinical Pathology (ASCP) LabQ Committee.